Orthostatic hypotension is not associated with small vessel disease progression or cognitive decline

被引:5
作者
Jacob, Mina A. [1 ]
Cai, Mengfei [1 ]
Jansen, Michelle G. [2 ]
van Elderen, Noortje [3 ]
Bergkamp, Mayra [1 ]
Claassen, Jurgen A. H. R. [3 ]
de Leeuw, Frank-Erik [1 ]
Tuladhar, Anil M. [1 ,4 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands
[2] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Dept Geriatr, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Neurol 910, Reinier Postlaan 4,POB 9101, NL-6500 HB Nijmegen, Netherlands
来源
CEREBRAL CIRCULATION - COGNITION AND BEHAVIOR | 2021年 / 2卷
关键词
Small vessel disease; Orthostatic hypotension; Progression; Cognitive decline; Mri; Cerebral hypoperfusion; CEREBRAL-BLOOD-FLOW; PRESSURE; IMPAIRMENT; RISK; CLASSIFICATION; INTEGRITY; DEMENTIA; PREDICTS;
D O I
10.1016/j.cccb.2021.100032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Cerebral hypoperfusion is thought to play an important role in the etiology of cerebral small vessel disease (SVD). Orthostatic hypotension (OH) is assumed to be a cause of cerebral hypoperfusion by causing recurrent hypoperfusion episodes, and might thus be related to progression of SVD. Here, we investigated whether presence of OH is associated with the progression of SVD MRI-markers and cognitive decline over a time period of 9 years in a cohort of sporadic SVD patients.Methods: This study included SVD patients from the RUN DMC study, a prospective longitudinal single-center cohort study. In total, 503 patients were included at baseline (2006), from whom 351 participated at first follow-up (2011), and 293 at second follow-up (2015). During all visits, patients underwent MRI and cognitive testing. Association between presence of OH at baseline and progression of SVD-markers on MRI and cognitive decline over time was estimated using linear mixed-effects models.Results: Of the 503 patients who participated at baseline, 46 patients (9.1%) had OH. Cross-sectional analysis of the baseline data showed that OH was associated with higher white matter hyperintensity (WMH) volume (13 = 0.18, p = 0.03), higher mean diffusivity (MD; 13 = 0.02, p = 0.002), and with presence of microbleeds (OR 2.37 95% CI 1.16-4.68). Longitudinally, OH was however not associated with a progression of total WMH volume (13 = -0.17, p = 0.96) or with higher MD (13 = -0.001, p = 0.49). There was no association between OH and cognitive performance, both at baseline and over time.Conclusion: In this longitudinal observational study, there was no evidence that presence of OH is associated with progression of SVD-markers or cognitive decline over time. Our findings indicate that OH may not be causally related to SVD progression over time
引用
收藏
页数:6
相关论文
共 50 条
[41]   Brain atrophy accelerates cognitive decline in cerebral small vessel disease The LADIS study [J].
Jokinen, H. ;
Lipsanen, J. ;
Schmidt, R. ;
Fazekas, F. ;
Gouw, A. A. ;
van der Flier, W. M. ;
Barkhof, F. ;
Madureira, S. ;
Verdelho, A. ;
Ferro, J. M. ;
Wallin, A. ;
Pantoni, L. ;
Inzitari, D. ;
Erkinjuntti, T. .
NEUROLOGY, 2012, 78 (22) :1785-1792
[42]   Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline [J].
Ostergaard, Leif ;
Engedal, Thorbjorn S. ;
Moreton, Fiona ;
Hansen, Mikkel B. ;
Wardlaw, Joanna M. ;
Dalkara, Turgay ;
Markus, Hugh S. ;
Muir, Keith W. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (02) :302-325
[43]   Disturbance of functional brain networks and cognitive decline in Parkinson?s disease: Severe cerebral small vessel disease aggravates this relationship [J].
Wan, Huijuan ;
Wu, Delong ;
Gao, Dongmei ;
Zhao, Xuemin ;
Wang, Shengsong ;
Huang, Jiuqing ;
Wang, Yilong ;
Zhang, Jianguo ;
Shao, Xiaoqiu .
PARKINSONISM & RELATED DISORDERS, 2023, 110
[44]   Recent progress on small vessel disease with cognitive impairment [J].
Gong, Li ;
Liu, Xue-Yuan ;
Fang, Min .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05) :7701-7709
[45]   Initial cognitive decline is associated with cortical thinning in early Parkinson disease [J].
Pereira, Joana B. ;
Svenningsson, Per ;
Weintraub, Daniel ;
Bronnick, Kolbjorn ;
Lebedev, Alexander ;
Westman, Eric ;
Aarsland, Dag .
NEUROLOGY, 2014, 82 (22) :2017-2025
[46]   Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease [J].
Dansson, Hakon Valur ;
Stempfle, Lena ;
Egilsdottir, Hildur ;
Schliep, Alexander ;
Portelius, Erik ;
Blennow, Kaj ;
Zetterberg, Henrik ;
Johansson, Fredrik D. .
ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
[47]   Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus [J].
Teng, Zhenjie ;
Feng, Jing ;
Liu, Ronghui ;
Dong, Yanhong ;
Chen, Huifang ;
Xu, Jing ;
Jiang, Xin ;
Li, Rui ;
Lv, Peiyuan .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 :1985-1994
[48]   Orthostatic hypotension and cognitive impairment: a dangerous association? [J].
Luisa Sambati ;
Giovanna Calandra-Buonaura ;
Roberto Poda ;
Pietro Guaraldi ;
Pietro Cortelli .
Neurological Sciences, 2014, 35 :951-957
[49]   Orthostatic Hypotension and Risk of Mild Cognitive Impairment and Dementia in Parkinson's Disease [J].
Hiorth, Ylva Hivand ;
Schulz, Joern ;
Pedersen, Kenn Freddy ;
Tysnes, Ole-Bjorn ;
Alves, Guido .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (11) :1365-1372
[50]   Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? [J].
Imamine, Rui ;
Kawamura, Takahiko ;
Umemura, Toshitaka ;
Umegaki, Hiroyuki ;
Kawano, Naoko ;
Hotta, Megumi ;
Kouchi, Yu ;
Hatsuda, Sawako ;
Watarai, Atsuko ;
Kanai, Akio ;
Nakashima, Eitaro ;
Sano, Takahisa ;
Sakakibara, Toshimasa ;
Nakamura, Jiro ;
Hotta, Nigishi .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (01) :91-99